On April 12, 2024, Apollomics Inc. received a comment letter from the United States Securities and Exchange Commission (SEC) regarding its Registration Statement on Form F-3, initially filed on April 1, 2024. The SEC conducted a limited review and requested that Apollomics provide additional information or amend the statement. The SEC's inquiry focuses on the company's operations in China, seeking clarification on whether Apollomics conducts the majority of its operations there and, if so, to provide more detailed disclosures about the associated legal and operational risks. The SEC referenced its previous guidance for China-based companies and noted that Apollomics' Amendment Number 4 to the Registration Statement on Form F-4, filed on February 21, 2023, had addressed similar issues. The SEC reminded Apollomics of its responsibility for the accuracy and adequacy of disclosures and advised allowing sufficient time for review of any amendments before the registration statement's requested effective date.

On April 12, 2024, Apollomics Inc. received a comment letter from the United States Securities and Exchange Commission (SEC) regarding its Registration Statement on Form F-3, initially filed on April 1, 2024. The SEC conducted a limited review and requested that Apollomics provide additional information or amend the statement. The SEC's inquiry focuses on the company's operations in China, seeking clarification on whether Apollomics conducts the majority of its operations there and, if so, to provide more detailed disclosures about the associated legal and operational risks. The SEC referenced its previous guidance for China-based companies and noted that Apollomics' Amendment Number 4 to the Registration Statement on Form F-4, filed on February 21, 2023, had addressed similar issues. The SEC reminded Apollomics of its responsibility for the accuracy and adequacy of disclosures and advised allowing sufficient time for review of any amendments before the registration statement's requested effective date.